Evidence map›Paper›PMID 42149581›Full record

ArticleJAMA neurology2026

Digital Sleep-Wake Cycle Metrics and Dementia Prediction in Older Adults.

Clémence Cavaillès, Ian Meneghel Danilevicz, Sam Vidil, Aurore Fayosse, Mathilde Chen, Vincent van Hees, Mika Kivimäki, Aline Dugravot, Archana Singh-Manoux, Séverine Sabia

Abstract read
In one paragraph

Article in JAMA neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Clémence CavaillèsUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.
Ian Meneghel DanileviczUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.
Sam VidilUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.
Aurore FayosseUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.
Mathilde ChenCIRAD, UMR PHIM, Montpellier, France.
Vincent van HeesAccelting, Almere, the Netherlands.
Mika KivimäkiFaculty of Brain Sciences, University College London, London, United Kingdom.
Aline DugravotUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.
Archana Singh-ManouxUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.
Séverine SabiaUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm U1153, INRAE, Centre for Research in Epidemiology and Statistics, Epidemiology of Ageing and Neurodegenerative Diseases, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Disruptions in the sleep-wake cycle have been reported in the preclinical period of dementia; whether they contribute to dementia prediction remains unclear. Objective: To examine associations of accelerometer-derived sleep-wake cycle metrics with incident dementia and their contribution to dementia risk prediction in models containing age and known risk factors. Design, Setting, and Participants: This study included 2 prospective UK population-based cohort studies: (1) UK Biobank (derivation study) and (2) Whitehall II (validation study). A UK Biobank accelerometer substudy was undertaken from 2013 to 2015, yielding accelerometer data on 103 278 participants. A Whitehall II accelerometer substudy was undertaken from 2012 to 2013 that provided data on 4267 participants. Analyses were performed between August 2024 and November 2025. Included participants were 60 years and older, without dementia, and with valid accelerometer and covariate data. Exposures: Thirty-six accelerometer-derived sleep-wake cycle metrics were extracted. A machine learning approach identified and combined metrics predicting dementia risk. Main Outcome and Measure: Incident all-cause dementia, ascertained from electronic health records. Results: Analyses were based on 53 448 UK Biobank participants (mean [SD] age, 67.5 [4.2] years; 28 448 female [54.2%]; mean [SD] follow-up, 7.8 [1.1] years) and 3965 Whitehall II participants (mean [SD] age, 69.4 [5.7] years; 1025 female [25.9%]; mean [SD] follow-up, 10.6 [2.4] years). In UK Biobank, 9 sleep-wake cycle metrics were combined in 2 components. Higher values in component 1 represented shorter durations and less frequent bouts of moderate to vigorous physical activity, more time in low-intensity activity, lower diversity of activity intensities, and higher probabilities to transition from activity to rest during daytime. Higher component 2 corresponded to more extreme sleep durations, longer wake bouts during sleep, lower probabilities to transition from wake to sleep, and earlier waking time. Both components were associated with higher dementia risk (component 1: hazard ratio [HR], 1.43; 95% CI, 1.33-1.54; component 2: HR, 1.10; 95% CI, 1.04-1.17) and improved prediction of a model including sociodemographic, behavioral, and health-related factors (increase in C index = 0.018; 95% CI, 0.011-0.025). Results were confirmed in the Whitehall II cohort study. Compared with an age-only prediction model, adding the components led to an increase in C index equivalent to that for APOE genotype. Conclusions and Relevance: Results of this cohort study show that accelerometer-derived sleep-wake cycle measures were associated with dementia, and made a modest, statistically significant contribution to its prediction. Future studies should evaluate their clinical utility as scalable markers alongside established predictors for early identification of individuals at risk of dementia.

Indexed as

DementiaSleepAccelerometryAgedCohort StudiesFemaleHumansMaleMiddle AgedProspective StudiesRisk FactorsUK BiobankUnited Kingdom

Identifiers

PMID42149581
PMCPMC13184784

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.